We’re excited to introduce some new additions to our team as well as new roles for at least one veteran.
Project Data Sphere® President Bill Louv, PhD, is stepping up to lead the organization as chief executive officer effective immediately. Louv had been serving as interim CEO since January, succeeding Ken Lee, who retired. He has led PDS since the CEO Roundtable formed the research organization in March 2018. Louv also has held key leadership positions in the pharmaceutical industry for nearly 30 years.
David M. Reese, MD, Executive Vice President of R&D at Amgen, has been elected to the Roundtable’s Board of Directors. Reese also will serve on the Board for PDS.
At Amgen, Reese oversees Discovery Research, Global Development, Global Regulatory Affairs and Safety, as well as Global Medical. Previously he served as Senior Vice President of Translational Sciences and Oncology, where he oversaw the translation of Amgen’s medicines from the lab into the clinic and the overall oncology strategy.
Major General Elder Granger, MD, President and CEO of THE 5Ps, LLC, also has been elected to the Roundtable Board of Directors. Granger consults in the areas of health care, education and leadership and recently became an ambassador for our Going for Gold program.
Prior to his retirement from the US Army in 2009, Granger served as the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, DC.
Aubrey Van Kirk Villalobos, DrPH, MEd, from the National Cancer Institute (NCI), will serve on the Health & Well-Being Council as a liaison with this important agency. She is a Health Scientist with the Implementation Science (IS) Team in the Office of the Director in the Division of Cancer Control and Population Sciences (DCCPS). In this role she leads efforts to advance the involvement of practitioners to help integrate evidence-based guidelines, programs, and policies for cancer control in public health and clinical practice. Her expertise will be critical as we continually seek to ensure the Cancer Gold Standard reflects the latest scientific evidence.
Jean-Charles Soria, Amgen’s senior vice president of Oncology within Global Development, joins our Life Sciences Council (LSC). The LSC brings together representatives of oncology pharmaceutical and biotechnology companies to advise the CEO Roundtable on Cancer about ways to enable research and development to deliver more effective oncology therapies to patients faster. Soria is a medical oncologist and holds a doctorate in molecular biology. Additionally, he has authored or co-authored more than 670 articles in leading international journals and has appeared on lists of the most influential research scientists in the world.
Welcome to three new Going for Gold Ambassadors! In addition to Granger, we’ve also added:
Roberto A. Gonzalez, founder and principle of RA Gonzalez & Associates, a Veteran Service-Disabled, Veteran-, Minority-Owned small business, and Co - Founder of Cornerstone & Associates LLC. He retired in 1995 from the United States Army in the grade of Lieutenant Colonel in the Medical Services Corp after 20 plus years of services. While in the Army, he served at various levels of management and responsibility including a position as the Military Assistant and Senior Advisor to two Assistant Secretaries of Defense for Health Affairs, which included the management of the Nations' second largest integrated health care system.
Fields Jackson, Jr., CEO and Chief Cheerleader of Racing Toward Diversity Magazine, Cary, NC. Racing Toward Diversity is a quarterly magazine that showcases the best diversity efforts and initiatives being made today. Jackson also is President of the College Diversity Network; Adjunct professor at Shaw University in Raleigh, NC; Distinguished Visiting Professor at South Carolina State University in Orangeburg, SC; and former Executive Director of the HBCU Business Dean Roundtable.